AI Assistant
Blog
Pricing
Log In
Sign Up
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
